title: [Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al].
authors.forename: R
authors.initials: R
authors.lastname: Hohlfeld
authors.forename: D
authors.initials: D
authors.lastname: Engelhardt
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010913:Pituitary-Adrenal System / Q000187:drug effects
chemical_list: D000305:Adrenal Cortex Hormones; D008775:Methylprednisolone
vernacular_title: Kortikosteroidtherapie bei Multipler Sklerose. Anmerkung zum Leserbrief von N. Haupts et al.